|
|
The Food and Drug Administration's Cancer Liaison
Program in the Office of Special Health Issues answers questions
directed to FDA by patients, their friends and family members
and patient advocates about therapies for life-threatening diseases.
This program incorporates the perspective of cancer patient
advocates into the drug development process allowing them an
opportunity to participate in the FDA drug review regulatory
process.
This program was charged with developing a process for recruiting,
assessing, and selecting patient representatives to serve as
members of cancer-related advisory committees
|
|
|
|
information related to cancer and approved cancer drug therapies
Provides patients, family members and members of the public
current information about clinical research studies, and basic
information about clinical trials
National Institute of Health information about cancer research,
cancer statistics, and other cancer-related information
|
|
|
Contact Us
|
|
|